推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Genotype is correlated with but does not predict virulence of Vibrio vulnificus biotype 1 in subcutaneously inoculated, iron dextran-treated mice

PC Thiaville, KL Bourdage, AC Wright… - Infection and …, 2011 - Am Soc Microbiol
Vibrio vulnificus is the leading cause of reported deaths from infections related to consumption
of seafood in the United States. Affected predisposed individuals frequently die rapidly from
sepsis. Otherwise healthy people can experience severe wound infection, which can lead ...
Related articles - All 4 versions

Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice

A Khalil, JR Goodhand, M Wahed… - European Journal of …, 2011 - journals.lww.com
Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining
your privacy and will not share your personal information without your express consent. For more
information, please refer to our Privacy Policy. ... Skip Navigation Links Home > ...

Accelerated total dose infusion of low molecular weight iron dextran is safe and efficacious in chronic kidney disease patients

S Sinha, D Chiu, G Peebles, P Swoboda… - QJM, 2011 - Oxford Univ Press
Background: Low molecular weight iron dextran (LMWID) is licensed for use as a total dose infusion
(TDI) over 4–6 h. In order to improve patient convenience and cost-effectiveness of therapy, we
investigated the safety and efficacy of adopting accelerated dosing regimens and ...
Cited by 2 - Related articles - All 5 versions

Safety profiles of total dose infusion of low‐molecular‐weight iron dextran and high‐dose iron sucrose in renal patients

H ATALAY, Y SOLAK, K ACAR… - Hemodialysis …, 2011 - Wiley Online Library
Abstract Iron sucrose and low-molecular-weight iron dextran (LMW-ID), two commonly used
iron solutions, have been compared in terms of allergic adverse event profiles to date.
However, the safety of total dose infusion of LMW-ID has been investigated by only one ...
Related articles - All 2 versions

Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron …

AB Pai, T Conner, CR McQuade, J Olp… - BioMetals, 2011 - Springer
Abstract Intravenous (IV) iron supplementation is widely used to support erythropoeisis in hemodialysis
patients. IV iron products are associated with oxida- tive stress that has been measured principally
by circulating biomarkers such as products of lipid peroxidation. The pro-oxidant effects of ...
Related articles - All 2 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451